Page 39 - E Ltd News Today

DCGI seeking more data for granting emergency use authorisation wont impact timeline for vaccine roll-out: Government The applications filed before the DCGI are being examined by the subject expert committee on COVID-19 of CDSCO for emergency use authorisation. Share Via Email   |  A+A A- By PTI NEW DELHI: The applications of Bharat Biotech, Serum Institute and Pfizer seeking emergency use authorisation for their COVID-19 vaccines are being examined, the Centre said on Tuesday asserting...

DCGI seeking more data for authorisation wont impact vaccine roll-out: Govt SECTIONS Last Updated: Dec 15, 2020, 10:24 PM IST Share Synopsis "This situation was factored-in from before as it is emergency use authorisation. There should be more than reasonable satisfaction about the safety, immunogenicity and effectiveness of the vaccine," NITI Aayog member (health) Dr V K Paul said. PTI "The applications are being examined on scientific basis, using the frameworks that are scientific, framework...

COVID-19 Vaccine| Representational Image (Photo Credits: IANS) New Delhi, Dec 11: The World Health Organization (WHO), national regulatory authorities and vaccine manufacturers in WHO South-East Asia Region discussed fast-tracking of Covid-19 vaccine rollout in member countries. "The vaccine manufacturing and regulatory sectors have a critical role to play inequitable and efficient deployment of vaccines," said Poonam Khetrapal Singh, Regional Director, WHO South-East Asia Region.  Aimed at s...

The World Health Organization (WHO), national regulatory authorities and vaccine manufacturers in WHO South-East Asia Region discussed fast-tracking of Covid-19 vaccine rollout in member countries. "The vaccine manufacturing and regulatory sectors have a critical role to play inequitable and efficient deployment of vaccines," said Poonam Khetrapal Singh, Regional Director, WHO South-East Asia Region. Aimed at strengthening collaboration between national programmes, vaccine producers and regu...

This was the second such meeting with vaccine manufacturers and regulators organised in WHO South East Asia Region, with the first held in April | World News

1361 New Delhi, December 11 The World Health Organization, national regulatory authorities and vaccine manufacturers in WHO South-East Asia Region discussed fast tracking of COVID-19 vaccine rollout in member countries, a statement said. "The vaccine manufacturing and regulatory sectors have a critical role to play in equitable and efficient deployment of vaccines," said Poonam Khetrapal Singh, Regional Director, WHO South-East Asia Region, at the two-day virtual meeting that ended on Friday. T...

The novel mRNA vaccine candidate, HGCO19, has been developed by Gennova and supported with a seed grant under the Ind-CEPI mission of the department of biotechnology of the Union ministry of science and technology. | Latest News India

WHO calls for covid-19 surveillance data on all risk groups for vaccination Premium (REUTERS) WHOs Immunization Technical Advisory Group said that while establishing collaboration with other health programmes and sectors for optimum delivery of vaccine, countries should leverage their experience in vaccine delivery for adults to find ways to reach eligible adults with covid-19 vaccines. Share Via Read Full Story New Delhi: There should be ensured availability of high-quality, complete and ti...

So far, the Indian regulator has not granted regulatory approvals to any vaccine candidate based on data generated during trials held in other countries. | Health

WHO, national regulators and vaccine manufacturers in South-East Asia Region discuss COVID-19 vaccines WHO, national regulators and vaccine manufacturers in South-East Asia Region discuss COVID-19 vaccines 11 December 2020 New Delhi:  The World Health Organization, national regulatory authorities and vaccine manufacturers in WHO South-East Asia Region discussed fast tracking of COVID-19 vaccine rollout in Member countries. “The vaccine manufacturing and regulatory sectors have a crit...